Dia Spectr
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hinnen, D.
Right arrow Articles by Vu, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hinnen, D.
Right arrow Articles by Vu, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Spectrum 17:60-64, 2004
© American Diabetes Association ®, Inc., 2004


Clinical Decision Making

Pharmaceutical Treatment of Hypertension and Dyslipidemia in People With Diabetes: An Educator’s Perspective: Part I: Hypertension

Deborah Hinnen, ARNP, BC-ADM, CDE, FAAN, Belinda P. Childs, ARNP, MN, BC-ADM, CDE, Melinda Maryniuk, MEd, RD, CDE and John Vu

The first 300 words of the full text of this article appear below.


    Case Presentation
 
M.J. is a 50-year-old white man who has had type 1 diabetes since age 20. He also has known retinopathy that has required laser treatment. He has no microalbuminuria. Treatment for depression was initiated more than 1 year ago. He has erectile dysfunction.

M.J. presents for his routine quarterly follow-up appointment with a blood pressure of 142/92 mmHg. He is on a four-shot insulin regimen using glargine and aspart. On physical exam, he has noted peripheral neuropathy. His family history includes hypothyroidism in his mother and hypertension in his father.

Physical examination and laboratory assays yield the following data:

  • Height: 72 inches
  • Weight: 171 lb
  • BMI: 23 kg/m2
  • Random capillary blood glucose: 126 mg/dl
  • Triglycerides: 105 mg/dl
  • Total cholesterol: 170 mg/dl
  • HDL cholesterol: 69 mg/dl
  • LDL cholesterol: 95 mg/dl
  • Creatinine: 1.2 mg/dl
  • Hemoglobin A1c: 7.5%
  • Electrocardiogram: normal
  • Stress thalium: normal

The patient’s current medications and supplements include:

  • ramipril, 5 mg daily initially (renal protection)
  • insulin: glargine, 16 units a.m. and 20 units p.m.; aspart, 2 units/15 g carbohydrate for breakfast and 1 unit/15 g carbohydrate for lunch, dinner, and snacks
  • simvastatin, 40 mg daily
  • aspirin, 325 mg daily
  • sertraline hydrochloride, 100 mg daily
  • alpha lipoic acid, 300 mg three times a day

M.J. does not have a regular physical activity program and eats most of his lunches in restaurants. He consumes one to four alcoholic beverages in the evening and does not smoke. Diet history reveals that the carbohydrate content of his lunches and dinners varies greatly from meal to meal. Snacks are usually from the vending machine at work. His diet is estimated to include a daily average of 2,400 calories made up of 35% total fat, 12% saturated fat, 13% protein, and 52% carbohydrate

He bases his insulin doses on a sliding scale and not by anticipating . . . [Full Text of this Article]


    Discussion
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.